Does BOTULINUM TOXIN NOS Cause C-reactive protein abnormal? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of C-reactive protein abnormal have been filed in association with BOTULINUM TOXIN NOS. This represents 2.9% of all adverse event reports for BOTULINUM TOXIN NOS.
8
Reports of C-reactive protein abnormal with BOTULINUM TOXIN NOS
2.9%
of all BOTULINUM TOXIN NOS reports
8
Deaths
8
Hospitalizations
How Dangerous Is C-reactive protein abnormal From BOTULINUM TOXIN NOS?
Of the 8 reports, 8 (100.0%) resulted in death, 8 (100.0%) required hospitalization, and 8 (100.0%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN NOS. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN NOS Cause?
Drug ineffective (99)
Off label use (75)
Product use in unapproved indication (44)
Migraine (40)
Treatment failure (39)
Headache (33)
Nausea (32)
Sedation (29)
Drug intolerance (28)
Pain (26)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which BOTULINUM TOXIN NOS Alternatives Have Lower C-reactive protein abnormal Risk?
BOTULINUM TOXIN NOS vs BOTULINUM TOXIN TYPE A
BOTULINUM TOXIN NOS vs BREMELANOTIDE
BOTULINUM TOXIN NOS vs BRENTUXIMAB
BOTULINUM TOXIN NOS vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN NOS vs BREO ELLIPTA